Large pharmaceutical companies are eager to talk about their digital transformation and their whole-hearted adoption of computational biology and artificial intelligence (AI). In the same vein, many are enthusiastically emphasizing the contributions digital pathology is making throughout their R&D organizations.
Digital pathology is helping pharma across the spectrum of drug discovery and development. (See Exhibit 1.) The technology digitizes hematoxylin...